COMMUNIQUÉS West-GlobeNewswire

Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
06/05/2026
Enrollment Now Completed for OPUS-1, OPUS-2 and OPUS-3 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults Topline Safety, Tolerability and Immunogenicity Data [...]
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
06/05/2026
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, [...]
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
06/05/2026
Phase 1a interim data for ongoing CTIM-76 (CLDN6 x CD3) trial expected in June 2026 Phase 1a interim data for ongoing CT-95 (MSLN x CD3) trial expected in September 2026 Phase 1 initiation for CT-202 (Nectin-4 x CD3) [...]
Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution
06/05/2026
Oslo, 6 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that the first [...]
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
06/05/2026
Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response NETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) (“BiomX” or the “Company”) today [...]
Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference
06/05/2026
NOVATO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra- [...]
OraSure Announces First Quarter 2026 Financial Results
06/05/2026
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/05/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 06 mai 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
electroCore Announces First Quarter 2026 Financial Results
06/05/2026
First quarter 2026 net sales of $9.6 million, an increase of 43% over $6.7 million in the first quarter 2025 Net loss of $5.3 million with Adjusted EBITDA net loss improving 24% from prior-year period to $2.3 million [...]
argenx to Present at BofA Securities 2026 Health Care Conference
06/05/2026
May 6, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen [...]
Mineralys Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
06/05/2026
– NDA for lorundrostat in adults with hypertension accepted by FDA; assigned PDUFA target date of December 22, 2026 – – Conference call today at 4:30 p.m. ET – RADNOR, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- Mineralys [...]
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
06/05/2026
LITTLETON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
06/05/2026
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
DLH Reports Fiscal 2026 Second Quarter Results
06/05/2026
ATLANTA, May 06, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital transformation and cybersecurity, systems engineering and integration, and science [...]
LifeMD Reports First Quarter 2026 Results
06/05/2026
First quarter 2026 revenue of $50.2 million and adjusted EBITDA loss of $4.5 million, above and in line, respectively, with the Company’s guidance. Gross margin increased approximately 420 basis points to 88%, versus [...]
Clover Health Reports First Quarter 2026 Results
06/05/2026
Business Highlights: Delivered positive GAAP Net Income in the first quarter of 2026, with strong performance across key metrics: Total revenues, Adjusted EBITDA, and Consolidated Gross Profit Market-leading Medicare [...]
Tenaya Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
06/05/2026
One-Year Cohort 1 Data and Initial Cohort 2 Data from RIDGE™-1 Phase 1b/2 Trial of TN-401 for PKP2-Associated ARVC to be Presented at ASGCT 2026 New Data from Both Cohorts of the MyPEAK™-1 Phase 1b/2 Trial of TN-201 for [...]
Alvotech Q1 2026 Financial Results
06/05/2026
Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long ‑ form earnings release providing additional operational details and business update for Q1 2026 is available at: [...]

Pages